158
Views
10
CrossRef citations to date
0
Altmetric
Review

Six-month depot formulation of leuprorelin acetate in the treatment of prostate cancer

&
Pages 259-267 | Published online: 05 Jun 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Rei Goto, Akihito Uda, Shinzo Hiroi, Kosuke Iwasaki, Kenta Takashima & Junichi Kurebayashi. (2017) Cost analysis of leuprorelin acetate in Japanese pre-menopausal breast-cancer patients: comparison between 6-month and 3-month depot formulations. Journal of Medical Economics 20:11, pages 1163-1169.
Read now
Rei Goto, Akihito Uda, Shinzo Hiroi, Kosuke Iwasaki, Kenta Takashima & Mototsugu Oya. (2017) Cost analysis of leuprorelin acetate in Japanese prostate cancer patients: comparison between 6-month and 3-month depot formulations. Journal of Medical Economics 20:11, pages 1155-1162.
Read now
Jaro Wex, Manpreet Sidhu, Isaac Odeyemi, Ahmed M Abou-Setta, Peny Retsa & Bertrand Tombal. (2013) Leuprolide acetate 1-, 3- and 6-monthly depot formulations in androgen deprivation therapy for prostate cancer in nine European countries: evidence review and economic evaluation. ClinicoEconomics and Outcomes Research 5, pages 257-269.
Read now
Ulf W Tunn, Damian Gruca & Peter Bacher. (2013) Six-month leuprorelin acetate depot formulations in advanced prostate cancer: a clinical evaluation. Clinical Interventions in Aging 8, pages 457-464.
Read now
E David Crawford & Jason M Phillips. (2011) Six-month gonadotropin releasing hormone (GnRH) agonist depots provide efficacy, safety, convenience, and comfort. Cancer Management and Research 3, pages 201-209.
Read now
Daniel Alexander Beyer, Feriel Amari, Marc Thill, Askan Schultze-Mosgau, Safaa Al-Hasani, Klaus Diedrich & Georg Griesinger. (2011) Emerging gonadotropin-releasing hormone agonists. Expert Opinion on Emerging Drugs 16:2, pages 323-340.
Read now

Articles from other publishers (4)

Yuichi Sato, Tatsuru Moritani, Ryota Inoue & Hirofumi Takeuchi. (2023) Preparation and evaluation of sustained release formulation of PLGA using a new injection system based on ink-jet injection technology. International Journal of Pharmaceutics 635, pages 122731.
Crossref
Girgis SamuelUddin NazimAhmed S. G. Srag El-Din. (2021) Physicochemical characterization of Novel Particulate Delivery Systems for Antitumor/metastatic Therapeutics. Research Journal of Pharmacy and Technology, pages 4837-4844.
Crossref
Yasuhiro Hijikata, Atsushi Hashizume, Shinichiro Yamada, Daisuke Ito, Haruhiko Banno, Keisuke Suzuki, Gen Sobue & Masahisa Katsuno. (2019) Long-term Effects of Androgen Deprivation in a Patient with Spinal and Bulbar Muscular Atrophy - A Case Report with 14 Years of Follow-up. Internal Medicine 58:15, pages 2231-2234.
Crossref
Saied Saeed Hosseiny Davarani, Ahmad Pourahadi & Peivand Ghasemzadeh. (2019) Quantification of controlled release leuprolide and triptorelin in rabbit plasma using electromembrane extraction coupled with HPLC–UV. ELECTROPHORESIS 40:7, pages 1074-1081.
Crossref